| Product NDC: | 58809-729 |
| Proprietary Name: | NASOPEN |
| Non Proprietary Name: | Phenylephrine Hydrochloride, Thonzylamine Hydrochloride |
| Active Ingredient(s): | 10; 50 mg/15mL; mg/15mL & nbsp; Phenylephrine Hydrochloride, Thonzylamine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 58809-729 |
| Labeler Name: | GM Pharmaceuticals, Inc |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20121003 |
| Package NDC: | 58809-729-04 |
| Package Description: | 118 mL in 1 BOTTLE (58809-729-04) |
| NDC Code | 58809-729-04 |
| Proprietary Name | NASOPEN |
| Package Description | 118 mL in 1 BOTTLE (58809-729-04) |
| Product NDC | 58809-729 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Phenylephrine Hydrochloride, Thonzylamine Hydrochloride |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20121003 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | GM Pharmaceuticals, Inc |
| Substance Name | PHENYLEPHRINE HYDROCHLORIDE; THONZYLAMINE HYDROCHLORIDE |
| Strength Number | 10; 50 |
| Strength Unit | mg/15mL; mg/15mL |
| Pharmaceutical Classes |